ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:AKE • FR0010313833

65.45 EUR
+0.6 (+0.93%)
Last: Feb 11, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, AKE scores 4 out of 10 in our fundamental rating. AKE was compared to 73 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AKE had positive earnings in the past year.
  • In the past year AKE had a positive cash flow from operations.
  • Each year in the past 5 years AKE has been profitable.
  • Each year in the past 5 years AKE had a positive operating cash flow.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

  • The Return On Assets of AKE (0.89%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 1.76%, AKE is in line with its industry, outperforming 47.95% of the companies in the same industry.
  • AKE has a Return On Invested Capital of 2.77%. This is comparable to the rest of the industry: AKE outperforms 47.95% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AKE is in line with the industry average of 7.31%.
Industry RankSector Rank
ROA 0.89%
ROE 1.76%
ROIC 2.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of AKE (1.38%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of AKE has declined.
  • AKE's Operating Margin of 5.40% is in line compared to the rest of the industry. AKE outperforms 53.42% of its industry peers.
  • In the last couple of years the Operating Margin of AKE has declined.
  • AKE's Gross Margin of 18.68% is on the low side compared to the rest of the industry. AKE is outperformed by 73.97% of its industry peers.
  • AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.4%
PM (TTM) 1.38%
GM 18.68%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

  • AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • AKE has more shares outstanding than it did 1 year ago.
  • AKE has less shares outstanding than it did 5 years ago.
  • AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AKE has an Altman-Z score of 1.90. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.90, AKE is not doing good in the industry: 69.86% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of AKE is 17.51, which is on the high side as it means it would take AKE, 17.51 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 17.51, AKE is in line with its industry, outperforming 52.05% of the companies in the same industry.
  • A Debt/Equity ratio of 0.57 indicates that AKE is somewhat dependend on debt financing.
  • The Debt to Equity ratio of AKE (0.57) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 17.51
Altman-Z 1.9
ROIC/WACC0.52
WACC5.33%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • AKE has a Current Ratio of 3.07. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AKE (3.07) is better than 86.30% of its industry peers.
  • AKE has a Quick Ratio of 2.26. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.26, AKE belongs to the best of the industry, outperforming 90.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.26
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

  • AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.40%.
  • AKE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.10% yearly.
  • The Revenue has decreased by -2.71% in the past year.
  • Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

  • AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.41% yearly.
  • Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 1.07% on average per year.
EPS Next Y-43.5%
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%
EPS Next 5Y-2.41%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.07%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

  • AKE is valuated correctly with a Price/Earnings ratio of 12.71.
  • Based on the Price/Earnings ratio, AKE is valued cheaply inside the industry as 86.30% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 28.23. AKE is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 13.03, which indicates a correct valuation of AKE.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 84.93% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (28.01), we can say AKE is valued rather cheaply.
Industry RankSector Rank
PE 12.71
Fwd PE 13.03
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • AKE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AKE is cheaper than 75.34% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than 73.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.49
EV/EBITDA 6.9
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • AKE's earnings are expected to decrease with -9.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)130.04
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.20%, AKE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.26, AKE pays a better dividend. On top of this AKE pays more dividend than 93.15% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.79, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.2%

5.2 History

  • On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 214.17% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
  • AKE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP214.17%
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (2/11/2026, 7:00:00 PM)

65.45

+0.6 (+0.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07
Earnings (Next)02-26
Inst Owners59.92%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.98B
Revenue(TTM)9.24B
Net Income(TTM)127.00M
Analysts71.43
Price Target62.02 (-5.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.2%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP214.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.47%
Min EPS beat(2)-10.34%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-11.01%
Min EPS beat(4)-18.44%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-6.6%
EPS beat(12)6
Avg EPS beat(12)-0.72%
EPS beat(16)10
Avg EPS beat(16)8.4%
Revenue beat(2)0
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.58%
Revenue beat(12)3
Avg Revenue beat(12)-1.09%
Revenue beat(16)7
Avg Revenue beat(16)0.41%
PT rev (1m)-3.01%
PT rev (3m)-12.99%
EPS NQ rev (1m)-22.41%
EPS NQ rev (3m)-33.96%
EPS NY rev (1m)-2.58%
EPS NY rev (3m)-18.11%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 12.71
Fwd PE 13.03
P/S 0.54
P/FCF 20.49
P/OCF 5.08
P/B 0.69
P/tB 2.27
EV/EBITDA 6.9
EPS(TTM)5.15
EY7.87%
EPS(NY)5.02
Fwd EY7.68%
FCF(TTM)3.19
FCFY4.88%
OCF(TTM)12.88
OCFY19.69%
SpS121.43
BVpS94.94
TBVpS28.82
PEG (NY)N/A
PEG (5Y)130.04
Graham Number104.89
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 1.76%
ROCE 3.93%
ROIC 2.77%
ROICexc 2.78%
ROICexgc 4.6%
OM 5.4%
PM (TTM) 1.38%
GM 18.68%
FCFM 2.63%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 17.51
Debt/EBITDA 3.1
Cap/Depr 89.12%
Cap/Sales 7.98%
Interest Coverage 20.79
Cash Conversion 73.91%
Profit Quality 191.34%
Current Ratio 3.07
Quick Ratio 2.26
Altman-Z 1.9
F-Score4
WACC5.33%
ROIC/WACC0.52
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-43.5%
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%
EPS Next 5Y-2.41%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.07%
EBIT growth 1Y-33.91%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year42.37%
EBIT Next 3Y16.8%
EBIT Next 5Y12.01%
FCF growth 1Y-53.98%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-22.65%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 5 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.


Is the dividend of ARKEMA sustainable?

The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 214.17%.